• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

两名感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）并接种疫苗后出现硬斑病的患者。

Morphea in two patients after being infected to and being vaccinated against SARS-CoV-2 infection.

作者信息

Aryanian Zeinab, Balighi Kamran, Hatami Parvaneh, Tootoonchi Nasim Mazloumi, Goodarzi Azadeh, Mohseni Afshar Zeinab

机构信息

Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran.

Department of Dermatology Babol University of Medical Sciences Babol Iran.

出版信息

Clin Case Rep. 2022 Apr 18;10(4):e05667. doi: 10.1002/ccr3.5667. eCollection 2022 Apr.

DOI:10.1002/ccr3.5667
PMID:35449768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9014706/
Abstract

Although the presence of morphea following COVID-19 has been rarely reported, the development of its generalized form following COVID-19 vaccination has not been reported yet. Here, we reported the first case of generalized morphea following COVID-19 vaccination and another similar case following SARS-Cov-2 infection. Other etiologic factors were also dealt with.

摘要

尽管新冠病毒病（COVID-19）后出现硬斑病的情况鲜有报道，但新冠病毒疫苗接种后出现其泛发型的情况尚未见报道。在此，我们报告了首例新冠病毒疫苗接种后泛发性硬斑病病例以及另一例新型冠状病毒（SARS-CoV-2）感染后的类似病例。同时也探讨了其他病因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c02/9014706/586fc3dc4cbd/CCR3-10-e05667-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c02/9014706/42271caa704e/CCR3-10-e05667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c02/9014706/586fc3dc4cbd/CCR3-10-e05667-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c02/9014706/42271caa704e/CCR3-10-e05667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c02/9014706/586fc3dc4cbd/CCR3-10-e05667-g003.jpg

相似文献

1
Morphea in two patients after being infected to and being vaccinated against SARS-CoV-2 infection.两名感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）并接种疫苗后出现硬斑病的患者。
Clin Case Rep. 2022 Apr 18;10(4):e05667. doi: 10.1002/ccr3.5667. eCollection 2022 Apr.
2
Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review.COVID 疫苗接种后泛发性硬斑病：两例患者系列病例及文献复习。
Dermatol Ther. 2022 Sep;35(9):e15709. doi: 10.1111/dth.15709. Epub 2022 Jul 20.
3
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.2021 年 5 月 1 日至 7 月 25 日，加利福尼亚州洛杉矶县≥16 岁人群中，根据疫苗接种状况划分的 SARS-CoV-2 感染和住院情况。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5.
4
Systemic COVID-19 Vaccination Enhances the Humoral Immune Response after SARS-CoV-2 Infection: A Population Study from a Hospital in Poland Criteria for COVID-19 Reimmunization Are Needed.全身性新冠病毒疫苗接种可增强感染新冠病毒后的体液免疫反应：一项来自波兰一家医院的人群研究 需要制定新冠病毒再次免疫的标准。
Vaccines (Basel). 2022 Feb 19;10(2):334. doi: 10.3390/vaccines10020334.
5
Decreasing neutralization antibody levels following vaccination against SARS-CoV-2 in the elderly: an observational study in Southern Moravia, Czech Republic.接种 SARS-CoV-2 疫苗后老年人中和抗体水平下降：捷克摩拉维亚南部的一项观察性研究。
Epidemiol Mikrobiol Imunol. 2022 Spring;71(1):9-20.
6
[Influence of SARS-CoV-2 vaccination on the epidemiological and clinical characteristics of imported COVID-19 cases in Chengdu].[新型冠状病毒疫苗接种对成都市输入性新冠肺炎病例流行病学及临床特征的影响]
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Aug 10;42(8):1365-1370. doi: 10.3760/cma.j.cn112338-20210330-00261.
7
Pansclerotic Morphea Following COVID-19: A Case Report and Review of Literature on Rheumatologic and Non-rheumatologic Dermatologic Immune-Mediated Disorders Induced by SARS-CoV-2.新型冠状病毒肺炎后泛硬化性硬斑病：1例报告及关于严重急性呼吸综合征冠状病毒2诱导的风湿性和非风湿性皮肤免疫介导疾病的文献综述
Front Med (Lausanne). 2021 Oct 20;8:728411. doi: 10.3389/fmed.2021.728411. eCollection 2021.
8
Comparison of SARS-CoV-2-Specific Antibodies in Human Milk after mRNA-Based COVID-19 Vaccination and Infection.基于mRNA的COVID-19疫苗接种和感染后母乳中SARS-CoV-2特异性抗体的比较。
Vaccines (Basel). 2021 Dec 14;9(12):1475. doi: 10.3390/vaccines9121475.
9
Linear Morphea in the Context of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Unique Dermatological Manifestation.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染背景下的线状硬皮病：一种独特的皮肤表现。
Cureus. 2024 Mar 27;16(3):e57031. doi: 10.7759/cureus.57031. eCollection 2024 Mar.
10
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗（灭活，Vero 细胞）有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.

引用本文的文献

1
Linear Morphea in the Context of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Unique Dermatological Manifestation.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染背景下的线状硬皮病：一种独特的皮肤表现。
Cureus. 2024 Mar 27;16(3):e57031. doi: 10.7759/cureus.57031. eCollection 2024 Mar.
2
A landscape on disorders following different COVID-19 vaccination: a systematic review of Iranian case reports.不同新冠病毒疫苗接种后疾病情况的综述：伊朗病例报告的系统评价
Eur J Med Res. 2023 Nov 26;28(1):542. doi: 10.1186/s40001-023-01531-7.
3
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.

本文引用的文献

1
Case of atypical disseminated herpes zoster in a patient with COVID-19: A diagnostic challenge in COVID era.1例新型冠状病毒肺炎（COVID-19）患者的非典型播散性带状疱疹：COVID时代的诊断挑战
Clin Case Rep. 2022 Feb 2;10(2):e05342. doi: 10.1002/ccr3.5342. eCollection 2022 Feb.
2
COVID-19 vaccine-related new-onset lichen planus.新型冠状病毒肺炎疫苗相关的新发扁平苔藓
Clin Case Rep. 2022 Feb 2;10(2):e05323. doi: 10.1002/ccr3.5323. eCollection 2022 Feb.
3
Serious health threat of mucormycosis during the ongoing COVID-19 pandemic: what dermatologists need to know in this regard.
COVID-19 疫苗接种对炎症性皮肤疾病和其他皮肤疾病的影响：已发表文献综述。
Viruses. 2023 Jun 23;15(7):1423. doi: 10.3390/v15071423.
4
Generalized morphea induced by the COVID-19 vaccine in a patient with chronic urticaria.新冠疫苗诱发慢性荨麻疹患者出现泛发性硬斑病。
Dermatol Reports. 2022 Dec 23;15(2):9632. doi: 10.4081/dr.2023.9632. eCollection 2023 Jun 7.
5
Generalized morphea following COVID-19 vaccine: Case report and literature review.新冠疫苗接种后泛发性硬斑病：病例报告及文献综述
Clin Case Rep. 2023 Mar 30;11(4):e7133. doi: 10.1002/ccr3.7133. eCollection 2023 Apr.
6
Unmasking sarcoidosis following SARS-CoV-2 vaccination: A case report.SARS-CoV-2疫苗接种后结节病的暴露：一例报告
Clin Case Rep. 2022 Dec 5;10(12):e6660. doi: 10.1002/ccr3.6660. eCollection 2022 Dec.
7
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.新冠疫苗接种后的皮肤反应：当前文献综述
Clin Cosmet Investig Dermatol. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. eCollection 2022.
8
COVID vaccine recommendations in dermatologic patients on immunosuppressive agents: Lessons learned from pandemic.皮肤科免疫抑制患者的 COVID 疫苗推荐：大流行期间的经验教训。
J Cosmet Dermatol. 2022 Dec;21(12):6568-6573. doi: 10.1111/jocd.15448. Epub 2022 Dec 12.
9
New-onset pemphigus foliaceus following SARS-CoV-2 infection and unmasking multiple sclerosis: A case report.新型冠状病毒感染后新发落叶型天疱疮并揭示多发性硬化症：一例报告
Clin Case Rep. 2022 Jun 3;10(6):e05910. doi: 10.1002/ccr3.5910. eCollection 2022 Jun.
在当前 COVID-19 大流行期间，毛霉菌病带来的严重健康威胁：皮肤科医生在此方面需要了解的内容。
Int J Dermatol. 2022 Aug;61(8):979-981. doi: 10.1111/ijd.16101. Epub 2022 Jan 30.
4
Cutaneous reactions to COVID-19 vaccine at the dermatology primary care.皮肤科初级保健中的 COVID-19 疫苗皮肤反应。
Immun Inflamm Dis. 2022 Feb;10(2):265-271. doi: 10.1002/iid3.568. Epub 2021 Nov 27.
5
COVID vaccination in patients under treatment with rituximab: A presentation of two cases from Iran and a review of the current knowledge with a specific focus on pemphigus.COVID 疫苗接种在接受利妥昔单抗治疗的患者中：来自伊朗的两例病例报告及当前知识的综述，特别关注天疱疮。
Dermatol Ther. 2022 Jan;35(1):e15216. doi: 10.1111/dth.15216. Epub 2021 Dec 1.
6
Morphea induced by SARS-CoV-2 infection: A case report.由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染引起的硬斑病：一例报告。
Int J Dermatol. 2022 Mar;61(3):377-378. doi: 10.1111/ijd.15983. Epub 2021 Nov 15.
7
Pansclerotic Morphea Following COVID-19: A Case Report and Review of Literature on Rheumatologic and Non-rheumatologic Dermatologic Immune-Mediated Disorders Induced by SARS-CoV-2.新型冠状病毒肺炎后泛硬化性硬斑病：1例报告及关于严重急性呼吸综合征冠状病毒2诱导的风湿性和非风湿性皮肤免疫介导疾病的文献综述
Front Med (Lausanne). 2021 Oct 20;8:728411. doi: 10.3389/fmed.2021.728411. eCollection 2021.
8
Pustular psoriasis flare-up in a patient with COVID-19.新冠病毒感染者脓疱型银屑病发作。
J Cosmet Dermatol. 2021 Nov;20(11):3364-3368. doi: 10.1111/jocd.14508. Epub 2021 Oct 7.
9
Influence of Narrow-Band Ultra Violet B Phototherapy on Homocysteine Status: A Prospective Study of Patients with Different Cutaneous Disorders.窄带紫外线 B 光疗对同型半胱氨酸状态的影响：对不同皮肤疾病患者的前瞻性研究。
Photobiomodul Photomed Laser Surg. 2021 Sep;39(9):607-611. doi: 10.1089/photob.2021.0025.
10
Cutaneous adverse effects of the available COVID-19 vaccines.现有 COVID-19 疫苗的皮肤不良反应。
Clin Dermatol. 2021 May-Jun;39(3):523-531. doi: 10.1016/j.clindermatol.2021.04.001. Epub 2021 Apr 27.